Carna Biosciences, Inc. announced that it has entered into agreement with new investor AthosAsiaEventDrivenMasterFund to issue 900,000 common shares at an issue price of ¥402.3 per share for the gross proceeds of ¥362,070,000 on May 15, 2024. The transaction has been approved by shareholders of the company and is expected to close on May 31, 2024. The company disclosed the issue expenses of ¥23,500,000 and the net proceeds of the transaction is ¥338,570,000.